In our series, elevation of CA19-9, carbohydrate antigen 12-5 (CA 12-5), and carcinoembryonic antigen were observed in 8 patients and most found in patients with NSCLC and gastrointestinal carcinoma. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.